Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20128-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#20128-1-AP, RRID:AB_10646430
- Product name
- KCTD15 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated KCTD15 antibody (Cat. #20128-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references KCTD15 Enhances Stem Cell-Like Properties and Promotes Triple-Negative Breast Cancer Progression Through KLF4/β-Catenin Signaling.
Pathogenic variants in KCTD1 disrupt cAMP signaling and cellular communication associated with developmental pathways.
KCTD1 regulation of Adenylyl cyclase type 5 adjusts striatal cAMP signaling.
KCTD15 inhibits the Hedgehog pathway in Medulloblastoma cells by increasing protein levels of the oncosuppressor KCASH2.
Yao L, Sun W, Xing J, Feng J
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2026 Feb 28;40(4):e71563
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2026 Feb 28;40(4):e71563
Pathogenic variants in KCTD1 disrupt cAMP signaling and cellular communication associated with developmental pathways.
Liao Y, Muntean BS
The Journal of biological chemistry 2025 Dec;301(12):110813
The Journal of biological chemistry 2025 Dec;301(12):110813
KCTD1 regulation of Adenylyl cyclase type 5 adjusts striatal cAMP signaling.
Liao Y, Muntean BS
Proceedings of the National Academy of Sciences of the United States of America 2024 Oct 22;121(43):e2406686121
Proceedings of the National Academy of Sciences of the United States of America 2024 Oct 22;121(43):e2406686121
KCTD15 inhibits the Hedgehog pathway in Medulloblastoma cells by increasing protein levels of the oncosuppressor KCASH2.
Spiombi E, Angrisani A, Fonte S, De Feudis G, Fabretti F, Cucchi D, Izzo M, Infante P, Miele E, Po A, Di Magno L, Magliozzi R, Guardavaccaro D, Maroder M, Canettieri G, Giannini G, Ferretti E, Gulino A, Di Marcotullio L, Moretti M, De Smaele E
Oncogenesis 2019 Nov 4;8(11):64
Oncogenesis 2019 Nov 4;8(11):64
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HEK-293 cells were subjected to SDS PAGE followed by western blot with 20128-1-AP(KCTD15 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of HepG2 cells, using KCTD15 antibody 20128-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line
